Menu
Gene and cell therapies can be highly beneficial in addressing rare diseases; however, they also can come at a high cost. This webinar will provide insight for decision makers in the Kentucky healthcare ecosystem on gene and cell therapies and position them to respond to their emergence in a manner that improves health and economic outcomes. The session will focus on introducing gene and cell therapies, highlighting their health impacts, reviewing economic implications, and considering their coverage in health benefit design.
